Insomnia Therapeutics Market Emerging Trends and Growth Drivers Through 2029 | Reach $3.98 Billion

 Drawing from trusted sources and expert analysis, this report helps businesses navigate the complex landscape of the insomnia therapeutics industry.





How Large Will The Insomnia Therapeutics Market Be By 2025?

The insomnia therapeutics market size has grown strongly in recent years. It will grow from $3.03 billion in 2024 to $3.2 billion in 2025 at a compound annual growth rate (CAGR) of 5.7%. The growth in the historic period can be attributed to the increasing prevalence of insomnia, growing awareness about sleep disorders, rising adoption of cognitive behavioral therapy for insomnia (CBT-I), expansion of pharmaceutical treatments, and growing use of over-the-counter sleep aids.



The insomnia therapeutics market size is expected to see strong growth in the next few years. It will grow to $3.98 billion in 2029 at a compound annual growth rate (CAGR) of 5.6%. The growth in the forecast period can be attributed to advancements in AI-driven sleep monitoring, increasing demand for personalized medicine, a growing geriatric population with sleep disorders, rising mental health awareness, and an expanding pipeline of novel insomnia drugs. Major trends in the forecast period include the integration of digital therapeutics in insomnia treatment, the rising preference for non-pharmacological therapies, the increasing adoption of wearable sleep trackers, the development of next-generation sleep medications, and the growth of telemedicine for sleep disorder management.



Get your free sample today:

Insomnia Therapeutics Report Market 2025, Drivers & Insights 2034 Sample



What Are Key Factors Driving The Demand In The Global Insomnia Therapeutics Market?

The increasing stress levels and lifestyle changes are expected to propel the growth of the insomnia therapeutics market going forward. Stress levels and lifestyle changes refer to the psychological and behavioral shifts in daily routines and responsibilities that contribute to emotional strain and disrupted sleep patterns. Rising stress levels and lifestyle changes are driven by constant digital connectivity, which erodes work-life boundaries and limits time for true mental rest. Insomnia therapeutics plays a crucial role by offering effective, science-backed treatment solutions that help restore healthy sleep patterns, reduce sleep-related anxiety, and support mental well-being amidst modern-day stressors. For instance, in May 2024, according to the American Psychiatric Association (APA), a US-based organization of psychiatrists, a share of U.S. adults reported feeling more anxious, rising from 32% in 2022 to 37% in 2023 and reaching 43% in 2024. Therefore, the increasing stress levels and lifestyle changes are contributing to the growth of the insomnia therapeutics market.



Comparative Analysis Of Leading Insomnia Therapeutics Market Segments

The insomnia therapeutics market covered in this report is segmented –



1) By Treatment Type: Drugs, Medical Devices

2) By Formulation: Tablets, Capsules, Liquid Solutions, Patches

3) By Route Of Administration: Oral, Intravenous, Transdermal, Other Routes Of Administration

4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Clinics, Wellness Centers



Subsegments:

1) By Drugs: Benzodiazepines, Nonbenzodiazepines, Antidepressants, Orexin Antagonists, Melatonin Antagonists, Other Drugs

2) By Medical Devices: Cognitive Behavioral Therapy Devices (CBT-I Devices), Polysomnography Devices, Sleep Tracking Devices, Neurostimulation Devices, Light Therapy Devices



What Are The Key Trends Shaping The Insomnia Therapeutics Industry?

Major companies in the insomnia therapeutics market are focused on developing advanced therapies such as dual orexin receptor antagonists (DORAs) to provide targeted treatment options with fewer side effects and improved safety profiles. A dual orexin receptor antagonist (DORA) is a class of medication that blocks both orexin-1 and orexin-2 receptors in the brain to promote sleep by inhibiting the wakefulness signaling pathway, commonly used in the treatment of insomnia. For instance, in June 2023, Idorsia Pharmaceuticals Ltd., a Switzerland-based pharmaceutical company, launched QUVIVIQ (daridorexant), a first-in-class dual orexin receptor antagonist (DORA) for the treatment of chronic insomnia disorder. The therapy is designed to reduce nighttime wakefulness without altering natural sleep architecture, offering patients improved sleep onset, maintenance, and daytime functioning. Its approval marks a significant advancement in insomnia treatment, providing a targeted mechanism of action distinct from traditional sedative-hypnotics and addressing the unmet need for long-term, non-habit-forming therapeutic options.



Who Are The Prominent Players In The Insomnia Therapeutics Business?

Major companies operating in the insomnia therapeutics market are Pfizer Inc., Sanofi S.A., Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Merck KGaA, Eisai Co. Ltd., Sumitomo Pharma Co. Ltd., Aurobindo Pharma, Astellas Pharma Inc., Acadia Pharmaceuticals Inc., Vanda Pharmaceuticals Inc., Idorsia Ltd, Minerva Neurosciences, Big Health, Neurovalens, Electromedical Products International Inc., Neurim Pharmaceuticals Ltd., Innovative Neurological Devices (IND), Blake Insomnia Therapeutics Inc., Cerêve Inc.



View the full insomnia therapeutics market report here:

Insomnia Therapeutics Report Market 2025, Drivers & Insights 2034



Which Region Is Expected To Lead The Insomnia Therapeutics Market By 2025?

North America was the largest region in the insomnia therapeutics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the insomnia therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.



Contact Us:



The Business Research Company



Market Research Reports



Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267



Email: info@tbrc.info





Follow Us On:



LinkedIn: The Business Research Company | LinkedIn

Comments

Post a Comment

Popular posts from this blog

Future of the Antifungals Market: Insights, Developments, and Strategic Overview

Image
 Ideal for market intelligence professionals and business strategists, this research uncovers where growth is headed in the antifungals industry. Antifungals Market Valuation Forecast: What Will The Market Be Worth By 2025? The antifungals market size has grown strongly in recent years. It will grow from $27.16 billion in 2024 to $29.6 billion in 2025 at a compound annual growth rate (CAGR) of 9.0%. The growth in the historic period can be attributed to fungal disease prevalence, aging population, healthcare infrastructure, awareness and education. The antifungals market size is expected to see strong growth in the next few years. It will grow to $41.2 billion in 2029 at a compound annual growth rate (CAGR) of 8.6%. The growth in the forecast period can be attributed to emerging fungal strains, regulatory approvals, global health concerns, increased healthcare spending, patient education and awareness. Major trends in the forecast period include research and development, ...
Read more

Polybutylene Terephthalate (PBT) Market Analysis 2025 – Supporting High-Stakes Corporate Planning

Image
 This report is designed for companies and decision-makers seeking actionable insights on market size, growth, trends, and competitive strategies to drive expansion and success in the Polybutylene Terephthalate (PBT) industry. What is the projected value of the polybutylene terephthalate (pbt) market by 2029? The polybutylene terephthalate (PBT) market size has grown strongly in recent years. It will grow from $2.5 billion in 2024 to $2.64 billion in 2025 at a compound annual growth rate (CAGR) of 5.5%. The growth in the historic period can be attributed to adoption in new industries, global economic conditions, electrical vehicle adoption, consumer goods and textile applications, advancements in material properties. The polybutylene terephthalate (PBT) market size is expected to see strong growth in the next few years. It will grow to $3.4 billion in 2029 at a compound annual growth rate (CAGR) of 6.5%. The growth in the forecast period can be attributed to continued focus on...
Read more

Zero Trust Security Market Report 2025 – Insights for Decision Makers and Market Strategists

Image
 For business leaders, corporate strategists, and growth-focused teams – this report delivers deep market intelligence, forecasts, segmentation, and competitor insights to guide your decisions through 2034. What is the forecasted revenue size of the zero trust security industry by 2029? The zero trust security market size has grown rapidly in recent years. It will grow from $38.45 billion in 2024 to $45.05 billion in 2025 at a compound annual growth rate (CAGR) of 17.2%. The growth in the historic period can be attributed to cyber threat landscape, legacy security challenges, digital transformation, remote workforce trend, data privacy concerns. The zero trust security market size is expected to see exponential growth in the next few years. It will grow to $99.24 billion in 2029 at a compound annual growth rate (CAGR) of 21.8%. The growth in the forecast period can be attributed to threat intelligence integration, user-centric security approach, data volume growth, business co...
Read more